{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T13:42:23Z","timestamp":1648906943790},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,6,28]],"date-time":"2013-06-28T00:00:00Z","timestamp":1372377600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s10753-013-9677-0","type":"journal-article","created":{"date-parts":[[2013,6,27]],"date-time":"2013-06-27T06:02:39Z","timestamp":1372312959000},"page":"1374-1382","source":"Crossref","is-referenced-by-count":4,"title":["CD4+CD25+Foxp3+ Regulatory T Cells Contribute in Liver Fibrosis Improvement with Interferon Alpha"],"prefix":"10.1007","volume":"36","author":[{"given":"L.","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. N.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y. M.","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,28]]},"reference":[{"issue":"2","key":"9677_CR1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller, R., and D.A. Brenner. 2005. Liver fibrosis. The Journal of Clinical Investigation 115(2): 209\u2013218.","journal-title":"The Journal of Clinical Investigation"},{"issue":"5","key":"9677_CR2","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3748\/wjg.15.578","volume":"15","author":"A Teufel","year":"2009","unstructured":"Teufel, A., A. Weinmann, C. Centner, et al. 2009. Hepatocellular carcinoma in patients with autoimmune hepatitis. World Journal of Gastroenterology 15(5): 578\u2013582.","journal-title":"World Journal of Gastroenterology"},{"issue":"4","key":"9677_CR3","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1074\/jbc.275.4.2247","volume":"275","author":"SL Friedman","year":"2000","unstructured":"Friedman, S.L. 2000. Molecrlar regulation of hepatic fibrosis, an integrated cellular response to tissue injury. Journal of Biological Chemistry 275(4): 2247\u20132250.","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"9677_CR4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1089-3261(05)70168-9","volume":"5","author":"E Albanis","year":"2001","unstructured":"Albanis, E., and S.L. Friedman. 2001. Hepatic fibrosis: pathogenesis and principles of therapy. Clinics in Liver Disease 5(2): 315\u2013334. v-vi.","journal-title":"Clinics in Liver Disease"},{"key":"9677_CR5","first-page":"237","volume":"117","author":"C Constandinou","year":"2005","unstructured":"Constandinou, C., N. Henderson, and J.P. Iredale. 2005. Modelling liver fibrosis in rodents. Methods in Molecular Medicine 117: 237\u2013250.","journal-title":"Methods in Molecular Medicine"},{"key":"9677_CR6","first-page":"244A","volume":"34","author":"JG McHutchison","year":"2001","unstructured":"McHutchison, J.G., G.L. Davis, R. Esteban, et al. 2001. Durability of sustained virological response in patients with chronic hepatitis C after treatment with Interferon alfa 2b alone or in combination with ribavirin. Hepatology 34: 244A.","journal-title":"Hepatology"},{"issue":"1","key":"9677_CR7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2004-823098","volume":"24","author":"EM Brunt","year":"2004","unstructured":"Brunt, E.M. 2004. Nonalcoholic steatohepatitis. Seminars in Liver Disease 24(1): 3\u201320.","journal-title":"Seminars in Liver Disease"},{"issue":"6","key":"9677_CR8","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0188-4409(02)00408-3","volume":"33","author":"MC Guti\u00e9rrez-Ru\u00edz","year":"2002","unstructured":"Guti\u00e9rrez-Ru\u00edz, M.C., G. Robles-D\u00edaz, and D. Kershenobich. 2002. Emerging concepts in inflammation and fibrosis. Archives of Medical Research 33(6): 595\u2013599.","journal-title":"Archives of Medical Research"},{"issue":"4","key":"9677_CR9","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-2893.2005.00671.x","volume":"12","author":"GV Papatheodoridis","year":"2005","unstructured":"Papatheodoridis, G.V., K. Petraki, E. Cholongitas, et al. 2005. Impact of interferon-alpha therapy on liver fibrosis progression in patients with HBeAg-negative chronic hepatitis B. Journal of Viral Hepatitis 12(4): 443.","journal-title":"Journal of Viral Hepatitis"},{"issue":"4","key":"9677_CR10","first-page":"353","volume":"99","author":"I Okazaki","year":"2002","unstructured":"Okazaki, I., T. Watanable, and Y. Inaqaki. 2002. Recent advance in understanding mechanisms of fibrogenesis and fibrolysis in hepatic fibrosis. Nihon Shokakibyo Gakkai Zasshi 99(4): 353\u2013364.","journal-title":"Nihon Shokakibyo Gakkai Zasshi"},{"issue":"10\u201311","key":"9677_CR11","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.gcb.2009.06.006","volume":"33","author":"T Povnard","year":"2009","unstructured":"Povnard, T., J. Massard, M. Rudler, et al. 2009. Impact of interferon-alpha treatment on liver fibrosis in patients with chronic hepatitis B: an overview of published trials. Gastroenterologie Clinique et Biologique 33(10\u201311): 916\u2013922.","journal-title":"Gastroenterologie Clinique et Biologique"},{"issue":"2","key":"9677_CR12","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0016-5085(99)70135-6","volume":"116","author":"R Sobesky","year":"1999","unstructured":"Sobesky, R., P. Mathurin, F. Charlotte, J. Moussalli, M. Olivi, M. Vidaud, V. Ratziu, et al. 1999. Modeling the impact of interferon alpha treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multivirc Group. Gastroenterology 116(2): 378\u2013386.","journal-title":"Gastroenterology"},{"issue":"5","key":"9677_CR13","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1053\/jhep.2000.19347","volume":"32","author":"T Poynard","year":"2000","unstructured":"Poynard, T., J. McHutchison, G.L. Davis, et al. 2000. Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C. Hepatology 32(5): 1131\u20131137.","journal-title":"Hepatology"},{"issue":"5","key":"9677_CR14","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/hep.1840040505","volume":"4","author":"A Frei","year":"1984","unstructured":"Frei, A., A. Zimmermann, and K. Weigand. 1984. The N-terminal propeptide of collagen type III in serum reflects activity and degree of fibrosis in patients with chronic liver disease. Hepatology 4(5): 830\u2013834.","journal-title":"Hepatology"},{"issue":"6","key":"9677_CR15","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/hep.1840190629","volume":"19","author":"VJ Desmet","year":"1994","unstructured":"Desmet, V.J., M. Gerber, J.H. Hoofnagle, M. Manns, and P.J. Scheuer. 1994. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 19(6): 1513\u20131520.","journal-title":"Hepatology"},{"issue":"2","key":"9677_CR16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/hep.1840200213","volume":"20","author":"M Chevallier","year":"1994","unstructured":"Chevallier, M., S. Guerret, P. Chosseqros, F. Gerard, and J.A. Grlmaud. 1994. A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: comparison with morphometric studies. Hepatology 20(2): 349\u2013355.","journal-title":"Hepatology"},{"key":"9677_CR17","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","volume":"134","author":"SL Friedman","year":"2008","unstructured":"Friedman, S.L. 2008. Mechanisms of hepatic fibrogenesis. Gastroenterology 134: 1655\u20131669.","journal-title":"Gastroenterology"},{"key":"9677_CR18","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/hep.1840380415","volume":"38","author":"Y Inaqaki","year":"2003","unstructured":"Inaqaki, Y., T. Nemoto, M. Kushida, et al. 2003. Interferon alfa down-regulates collagen gene transcription and suppresses experimental hepatic fibrosis in mice. Hepatology 38: 890\u2013899.","journal-title":"Hepatology"},{"issue":"10","key":"9677_CR19","first-page":"919","volume":"33","author":"HX Yang","year":"2008","unstructured":"Yang, H.X., and Y.R. Yi. 2008. Curative effect of interferon-alpha\u00a0on rat liver fibrosis induced by CCl4. Zhong Nan Da Xue Xue Bao. Yi Xue Ban 33(10): 919\u2013925.","journal-title":"Zhong Nan Da Xue Xue Bao. Yi Xue Ban"},{"issue":"3","key":"9677_CR20","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1053\/j.gastro.2004.04.062","volume":"127","author":"R Safdal","year":"2004","unstructured":"Safdal, R., M. Ohta, C.E. Alvarez, et al. 2004. Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes. Gastroenterology 127(3): 870\u2013882.","journal-title":"Gastroenterology"},{"issue":"6","key":"9677_CR21","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1002\/hep.21438","volume":"44","author":"M Abel","year":"2006","unstructured":"Abel, M., D. S\u00e8ne, S. Pol, et al. 2006. Intrahepatic virus-specific IL-10- producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection. Hepatology 44(6): 1607\u20131616.","journal-title":"Hepatology"},{"issue":"3","key":"9677_CR22","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1517\/14728222.12.3.313","volume":"12","author":"MH Zheng","year":"2008","unstructured":"Zheng, M.H., D.N. Gu, M. Braddock, et al. 2008. CD4 + CD25 + regulatory T cells: a therapeutic target for liver diseases. Expert Opinion on Therapeutic Targets 12(3): 313\u2013326.","journal-title":"Expert Opinion on Therapeutic Targets"},{"issue":"7","key":"9677_CR23","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","volume":"8","author":"DA Viqnali","year":"2008","unstructured":"Viqnali, D.A., L.W. Collison, and C.J. Workman. 2008. How regulatory T cells work. Nature Reviews Immunology 8(7): 523\u2013532.","journal-title":"Nature Reviews Immunology"},{"issue":"2","key":"9677_CR24","doi-asserted-by":"crossref","first-page":"G628","DOI":"10.1152\/ajpgi.00137.2006","volume":"292","author":"A Horani","year":"2007","unstructured":"Horani, A., N. Muhanna, O. Pappo, et al. 2007. Beneficial effect of glatiramer acetate (Copaxone) on immune modulation of experimental hepatic fibrosis. American Journal of Physiology\u2014Gastrointestinal and Liver Physiology 292(2): G628\u2013G638.","journal-title":"American Journal of Physiology\u2014Gastrointestinal and Liver Physiology"},{"issue":"9","key":"9677_CR25","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1097\/HJH.0b013e328349c62d","volume":"29","author":"P Kanellakis","year":"2011","unstructured":"Kanellakis, P., T.N. Dinh, A. Agrotis, and A. Bobik. 2011. CD4 + CD25 + Foxp3 + regulatory T cells suppress cardiac fibrosis in the hypertensive heart. Journal of Hypertension 29(9): 1820\u20131828.","journal-title":"Journal of Hypertension"},{"issue":"12","key":"9677_CR26","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1164\/rccm.200812-1936OC","volume":"179","author":"I Kotsianidis","year":"2009","unstructured":"Kotsianidis, I., E. Nakou, I. Bouchliou, et al. 2009. Global impairment of CD4 + CD25 + FOXP3 + regulatory T cells in idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine 179(12): 1121\u20131130.","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"3","key":"9677_CR27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1755-1536-3-18","volume":"3","author":"G Trujillo","year":"2010","unstructured":"Trujillo, G., A.J. Hartigan, and C.M. Hoqaboam. 2010. T regulatory cells and attenuated bleomycin-induced fibrosis in lungs of CCR7\u2212\/\u2212 mice. Fibrogenesis Tissue Repair 3(3): 18.","journal-title":"Fibrogenesis Tissue Repair"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-013-9677-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10753-013-9677-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-013-9677-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T23:38:14Z","timestamp":1559259494000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10753-013-9677-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,28]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["9677"],"URL":"https:\/\/doi.org\/10.1007\/s10753-013-9677-0","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,28]]}}}